| [1] Camassola M, de Macedo Braga LM, Chagastelles PC,et al. Methodology, biology and clinical applications of human mesenchymal stem cells. Methods Mol Biol. 2012;879: 491-504.[2] Fan X, Liu T, Liu Y,et al. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design. Biotechnol Prog. 2009;25(2): 499-507.[3] Boquest AC, Collas P. Obtaining freshly isolated and cultured mesenchymal stem cells from human adipose tissue. Methods Mol Biol. 2012;879:269-278.[4] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.[5] da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26(9):2287-2299.[6] Ngoc PK, Phuc PV, Nhung TH,et al. Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells. Hum Cell. 2011;24(2):86-95.[7] Hwang JH, Lee MJ, Seok OS,et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies.Cytokine. 2010;49(1): 95-101.[8] Sumanasinghe RD, Pfeiler TW, Monteiro-Riviere NA,et al. Expression of proinflammatory cytokines by human mesenchymal stem cells in response to cyclic tensile strain. J Cell Physiol. 2009;219(1):77-83.[9] Huang XP, Sun Z, Miyagi Y,et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation. 2010;122(23):2419-2429.[10] Schu S, Nosov M, O'Flynn L,et al. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med. 2012; 16(9):2094-2103.[11] Liu L, Zhao X, Li P,et al. A novel way to isolate MSCs from umbilical cords. Eur J Immunol. 2012;42(8):2190-2193.[12] Pierini M, Dozza B, Lucarelli E,et al. Efficient isolation and enrichment of mesenchymal stem cells from bone marrow. Cytotherapy. 2012;14(6):686-693.[13] Chieregato K, Castegnaro S, Madeo D,et al. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue. Cytotherapy. 2011;13(8):933-943.[14] Meyerrose T, Olson S, Pontow S,et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev. 2010;62(12):1167-1174.[15] Nekanti U, Mohanty L, Venugopal P,et al. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res. 2010;5(3):244-254.[16] Felka T, Schäfer R, De Zwart P,et al. Animal serum-free expansion and differentiation of human mesenchymal stromal cells. Cytotherapy. 2010;12(2):143-153.[17] Jung S, Sen A, Rosenberg L,et al. Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy. 2010; 12(5):637-657.[18] Jung S, Panchalingam KM, Rosenberg L,et al. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012;2012:123030.[19] Hatlapatka T, Moretti P, Lavrentieva A,et al. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions.Tissue Eng Part C Methods. 2011;17(4): 485-493.[20] Poloni A, Maurizi G, Serrani F,et al. Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate. Cell Prolif. 2012;45(1):66-75.[21] Pérez-Simon JA, López-Villar O, Andreu EJ,et al. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 2011;96(7):1072-1076.[22] Ben Azouna N, Jenhani F, Regaya Z,et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther. 2012;3(1):6.[23] Tekkatte C, Vidyasekar P, Kapadia NK,et al. Enhancement of adipogenic and osteogenic differentiation of human bone-marrow-derived mesenchymal stem cells by supplementation with umbilical cord blood serum. Cell Tissue Res. 2012;347(2):383-395.[24] Phadnis SM, Joglekar MV, Venkateshan V,et al. Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells.In Vitro Cell Dev Biol Anim. 2006;42(10): 283-286.[25] Duggal S, Brinchmann JE. Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells. J Cell Physiol. 2011;226(11): 2908-2915.[26] Shetty P, Bharucha K, Tanavde V. Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biol Int. 2007;31(3):293-298.[27] Ma HY, Yao L, Yu YQ,et al. An effective and safe supplement for stem cells expansion ex vivo: cord blood serum.Cell Transplant. 2012;21(5):857-869.[28] Jung J, Moon N, Ahn JY,et al. Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential.Stem Cells Dev. 2009;18(4):559-571. [29] Gottipamula S, Sharma A, Krishnamurthy S,et al. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett. 2012;34(7):1367-1374.[30] Xia W, Li H, Wang Z,et al. Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int. 2011;35(6):639-643.[31] Abdelrazik H, Spaggiari GM, Chiossone L,et al. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol. 2011;41(11):3281-3290.[32] Eibes G, dos Santos F, Andrade PZ,et al. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol. 2010; 146(4):194-197.[33] dos Santos F, Andrade PZ, Eibes G,et al. Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol. 2011;698:189-198.[34] Dos Santos F, Andrade PZ, Boura JS,et al. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol. 2010;223(1):27-35.[35] de la Fuente R, Bernad A, Garcia-Castro J,et al. Retraction: Spontaneous human adult stem cell transformation. Cancer Res. 2010;70(16):6682.[36] Rubio D, Garcia-Castro J, Martín MC,et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65(8): 3035-3039.[37] Ramasamy R, Lam EW, Soeiro I,et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 2007;21(2):304-310.[38] Tian LL, Yue W, Zhu F,et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol. 2011;226(7):1860-1867.[39] Kucerova L, Matuskova M, Hlubinova K,et al. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010;9:129.[40] Kurtova AV, Balakrishnan K, Chen R,et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion- mediated drug resistance. Blood. 2009;114(20): 4441-4450.[41] Vianello F, Villanova F, Tisato V,et al. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica. 2010;95(7): 1081-1089.[42] Spaeth EL, Dembinski JL, Sasser AK,et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 2009;4(4):e4992.[43] Takeuchi M, Takeuchi K, Kohara A,et al. Chromosomal instability in human mesenchymal stem cells immortalized with human papilloma virus E6, E7, and hTERT genes. In Vitro Cell Dev Biol Anim. 2007;43(3-4):129-138. |
